Veteran-owned business
Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.

For research use only. Not for human consumption.

CJC-1295 (NO DAC) (5mg)

CJC-1295 (NO DAC) is a short-acting synthetic peptide analog of growth hormone–releasing hormone (GHRH) that stimulates pulsatile growth hormone release for research purposes. It is used to study GH regulation, IGF‑1 production, and metabolic effects, without the prolonged activity of the DAC version.

Price:

$50.00

Select Quantity:

4 in stock

Overview

CJC-1295 (NO DAC) is a synthetic, short-acting peptide analog of growth hormone–releasing hormone (GHRH) designed to stimulate natural, pulsatile growth hormone (GH) secretion. Unlike the DAC (Drug Affinity Complex) version, it has a short half-life, resulting in brief, physiologically relevant GH pulses rather than prolonged hormone exposure.

Key Points

  • Type: Synthetic GHRH analog (30 amino acids)

  • Action: Binds to GHRH receptors in the anterior pituitary, triggering GH release

  • Duration: Short-acting; half-life of a few hours

  • Effect: Increases GH and IGF-1 levels, influencing metabolism, fat loss, lean muscle growth, and tissue repair

  • Use: Primarily research and experimental applications; not approved for clinical therapy

Applications in Research

  • Studying growth hormone pulsatility and feedback mechanisms

  • Investigating body composition changes and metabolic effects

  • Evaluating exercise recovery and tissue repair in experimental models


Summary:
CJC-1295 (NO DAC) is a short-acting, research-use peptide that mimics natural GHRH activity, producing acute, pulsatile GH release to study hormonal regulation, metabolism, and growth-related processes.

Biochemical
Characteristics

1. Peptide Nature

  • Type: Synthetic peptide analog of growth hormone–releasing hormone (GHRH)

  • Length: 30 amino acids

  • Modification: Chemically stabilized at key sites to resist enzymatic degradation, but short-acting (unlike the DAC version)

  • Linear Structure: Does not form complex tertiary structures; largely maintains an α-helical conformation critical for receptor binding


2. Structural Features

  • Amphipathic: Contains both hydrophilic and hydrophobic residues for solubility and receptor interaction

  • Receptor Binding Domain: Designed to bind GHRH receptors in the anterior pituitary efficiently

  • Stability Enhancements: Substitutions at vulnerable peptide bonds increase resistance to proteases without extending half-life


3. Solubility & Stability

  • Formulation: Lyophilized powder for reconstitution

  • Solubility: Water-soluble for injection

  • Storage Stability: Stable when refrigerated (2–8 °C), sensitive to heat and strong agitation

  • Half-Life: Short, typically 1–2 hours, allowing pulsatile GH release


4. Functional Biochemistry

  • GH Release: Stimulates pituitary somatotrophs to secrete growth hormone in pulses

  • IGF-1 Modulation: GH release indirectly increases circulating insulin-like growth factor 1 (IGF-1)

  • Metabolic Impact: Supports lean body mass increase, fat metabolism, and tissue repair

  • Receptor Signaling: Activates intracellular cAMP and related pathways in GH-producing cells


5. Summary

CJC-1295 (NO DAC) is a synthetic, short-acting linear peptide with α-helical regions and receptor-specific binding sites, chemically stabilized to resist enzymatic breakdown. Its biochemical design enables pulsatile GH release, IGF-1 induction, and metabolic modulation in research studies.

Research Applications

1. Growth Hormone Regulation

  • Studying GH Pulsatility: Used to mimic natural pulsatile growth hormone secretion in research studies.

  • Pituitary Function Research: Helps investigate GHRH receptor signaling and feedback mechanisms in the anterior pituitary.


2. IGF-1 and Metabolic Studies

  • IGF-1 Modulation: Indirectly increases insulin-like growth factor 1, useful in studies of growth and metabolism.

  • Metabolic Research: Evaluates effects on fat metabolism, lean muscle growth, and body composition in experimental models.


3. Exercise and Recovery Research

  • Muscle Repair: Assesses GH-mediated improvements in muscle recovery post-injury or exercise.

  • Tissue Regeneration: Studied for potential effects on collagen synthesis and tissue repair mechanisms.


4. Endocrinology & Hormone Therapy Research

  • GHRH Analog Studies: Serves as a model to compare short-acting vs long-acting GH secretagogues.

  • Drug Development: Provides insight for next-generation GH therapies and pulsatile hormone delivery systems.


5. Key Considerations

  • Investigational Use: Not FDA-approved; only used in controlled research studies.

  • Dosing: Frequent injections needed due to short half-life.

  • Focus: Acute GH responses, rather than long-term sustained GH elevation.


Summary:
CJC-1295 (NO DAC) is primarily used in research to study growth hormone pulsatility, IGF-1 regulation, metabolic effects, and tissue repair, providing short-term GH stimulation without prolonged accumulation.

Chemical Properties
COA /HPLC / MS

3rd Party Testing
Storage

1. Lyophilized (Powder) Form

  • Temperature: Store refrigerated at 2–8 °C (36–46 °F).

  • Light Protection: Keep away from direct light.

  • Moisture Protection: Keep in the original sealed vial to prevent moisture exposure.

  • Shelf Life: Typically up to 24 months when stored properly.


2. Reconstituted Solution

  • Temperature:

    • Refrigerated: 2–8 °C for short-term use

    • Room Temperature: Only for very brief periods (generally ≤24 hours)

  • Handling:

    • Use sterile syringes

    • Avoid vigorous shaking; gently swirl to mix

  • Appearance Check: Solution should be clear to slightly opalescent; discard if cloudy or particulate matter appears


3. General Handling Tips

  • Do not freeze reconstituted peptide; freezing can denature it

  • Avoid heat and light exposure for both lyophilized and reconstituted forms

  • Use promptly after reconstitution to maintain activity


Summary:
CJC-1295 (NO DAC) is most stable as a refrigerated lyophilized powder. After reconstitution, it should be used immediately or stored refrigerated for a very short period to preserve potency.

Your cart is currently empty.

Return to shop

0